Colgate-Palmolive earnings date
Colgate-Palmolive's next results are expected on October 30, 2026. Watch North American volume and market share together.
What has Colgate-Palmolive guided for the year?
Colgate maintained its net-sales growth forecast at 2.0%–6.0%. It kept its organic-sales forecast at 1.0%–4.0%. The worldwide oral-care market is forecast to grow 8.9% over the same period, so Colgate’s organic guide looks modest.
| Period guided | Low | High | Date given | |
|---|---|---|---|---|
| Net sales growth (%) | Year to Dec 2026 | 2.0% | 6.0% | Jul 31, 2026 |
| Organic sales growth (%) | Year to Dec 2026 | 1.0% | 4.0% | Jul 31, 2026 |
| Gross profit margin, GAAP (year-over-year change) | Year to Dec 2026 | Jul 31, 2026 | ||
| Advertising, percentage of net sales (year-over-year change) | Year to Dec 2026 | Jul 31, 2026 | ||
| Earnings per share growth, Base Business (%) | Year to Dec 2026 | Jul 31, 2026 | ||
| Capital expenditures (% of Net sales) | Year to Dec 2026 | 3.0% | 3.0% | Jul 31, 2026 |
What this means. The retirement benefit payment figures are estimates of total payments from pension assets and the company, not necessarily cash the company itself will pay.
Did Colgate-Palmolive keep its past promises?
The record is mixed. Management forecast organic sales growth of 3% to 5% for 2025. It delivered 1.4%. The previous year was stronger, with 7.4% organic growth and 11% growth in base-business earnings per share, so shareholders should recognize that success while retaining the original 2025 forecast as an accountability benchmark.
How have Colgate-Palmolive's revenue and profit trended?
The June 2026 quarter showed improvement, but the recovery still had important qualifications. Revenue increased year on year, and organic growth included both volume and pricing. Currency and Prime100 lifted the reported headline, so reported growth overstated the underlying pace.
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5,361 | 5,324 | 5,230 | 5,131 | 5,110 | 4,911 | 4,944 | 5,033 |
| Gross margin | 61.5% | 60.6% | 60.2% | 59.4% | 60.1% | 60.8% | 60.3% | 61.1% |
| Operating income | 1,016 | 964 | 92 | 1,059 | 1,080 | 1,076 | 1,064 | 1,065 |
| Net income | 693 | 646 | -37 | 735 | 743 | 690 | 739 | 737 |
| EPS, diluted | 0.86 | 0.80 | -0.05 | 0.91 | 0.91 | 0.85 | 0.90 | 0.90 |
| = Free cash flow | 867 | 609 | 1,276 | 1,106 | 776 | 476 | 1,085 | 1,033 |
What this means. The very low profit in December 2025 is mainly because the company recorded a large one-time charge related to its skin-health business, not because normal sales suddenly disappeared.
What should you watch in Colgate-Palmolive's next release?
On October 30, Colgate will report its third-quarter results. Watch North American volume and market share together: volume measures units sold, while market share measures Colgate’s portion of consumer purchases. Higher shipments could merely mean retailers are rebuilding inventory. Organic growth may also look better as the private-label exit becomes an easier comparison, without showing faster underlying demand.